Genetic and epigenetic networks in intellectual disabilities.

Mutations in more than 450 different genes have been associated with intellectual disability (ID) and related cognitive disorders (CDs), such as autism. It is to be expected that this number will increase three to fourfold in the next years due to the rapid implementation of innovative high-throughput sequencing technology in genetics labs. Numerous functional relationships have been identified between the products of individual ID genes, and common molecular and cellular pathways onto which these networks converge are beginning to emerge. Prominent examples are genes involved in synaptic plasticity, Ras and Rho GTPase signaling, and epigenetic genes that encode modifiers of the chromatin structure. It thus seems that there might be common pathological patterns in ID, despite its bewildering genetic heterogeneity. These common pathways provide attractive opportunities for knowledge-based therapeutic interventions.

[1]  B. D. de Vries,et al.  Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome , 2005, Journal of Medical Genetics.

[2]  J. Gécz,et al.  Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. , 2006, American journal of human genetics.

[3]  S. Christian,et al.  Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum. , 2008, Nature genetics.

[4]  L. Biesecker,et al.  Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR , 2004, Nature Genetics.

[5]  Annette Schenck,et al.  CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. , 2009, American journal of human genetics.

[6]  M. Shaw,et al.  Mutations in PHF6 are associated with Börjeson–Forssman–Lehmann syndrome , 2002, Nature Genetics.

[7]  Nathalie Boddaert,et al.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. , 2007, American journal of human genetics.

[8]  K. Friend,et al.  Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. , 2007, American journal of human genetics.

[9]  Y. Humeau,et al.  IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation , 2007, Proceedings of the National Academy of Sciences.

[10]  Y. Elgersma,et al.  Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. , 2008, Trends in genetics : TIG.

[11]  Yi Zhang,et al.  Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes , 2010, Science.

[12]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[13]  M. Digilio,et al.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. , 2002, American journal of human genetics.

[14]  C. Napoli,et al.  Mediator complexes and eukaryotic transcription regulation: an overview. , 2007, Biochimie.

[15]  M. Digilio,et al.  Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum , 2009, Human mutation.

[16]  C. Schwartz,et al.  A missense mutation in CASK causes FG syndrome in an Italian family. , 2009, American journal of human genetics.

[17]  D. Molfese,et al.  Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.

[18]  R. Jaenisch,et al.  Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 , 2007, Proceedings of the National Academy of Sciences.

[19]  Juliane Hoyer,et al.  Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation , 2006, American journal of medical genetics. Part A.

[20]  Pablo Rodriguez-Viciana,et al.  Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome , 2006, Science.

[21]  A. Addington,et al.  Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. , 2009, The New England journal of medicine.

[22]  M. Rauh,et al.  Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) , 2005, Nature Genetics.

[23]  F. Cremers,et al.  CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation , 2010, Human Genetics.

[24]  J. Gécz,et al.  Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. , 2010, American journal of human genetics.

[25]  C. Vlangos,et al.  Mutations in RAI1 associated with Smith–Magenis syndrome , 2003, Nature Genetics.

[26]  H. R. Crollius,et al.  Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation , 1998, Nature.

[27]  Andrew Menzies,et al.  Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. , 2007, American journal of human genetics.

[28]  Kam Y. J. Zhang,et al.  Germline KRAS mutations cause Noonan syndrome , 2006, Nature Genetics.

[29]  J. Lacaille,et al.  De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism , 2011, Biological Psychiatry.

[30]  Ravi Iyengar,et al.  Mutation in SHOC2 promotes aberrant protein N-myristoylation and underlies Noonan-like syndrome with loose anagen hair , 2009, Nature Genetics.

[31]  Katarzyna Chawarska,et al.  Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. , 2008, American journal of human genetics.

[32]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[33]  M. Giustetto,et al.  Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. , 2011, Human molecular genetics.

[34]  Naomichi Matsumoto,et al.  De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.

[35]  C. Walsh,et al.  PAK3 mutation in nonsyndromic X-linked mental retardation , 1998, Nature Genetics.

[36]  Christina Gross,et al.  Dysregulated Metabotropic Glutamate Receptor-Dependent Translation of AMPA Receptor and Postsynaptic Density-95 mRNAs at Synapses in a Mouse Model of Fragile X Syndrome , 2007, The Journal of Neuroscience.

[37]  J. Sweatt,et al.  Increased Histone Acetyltransferase and Lysine Acetyltransferase Activity and Biphasic Activation of the ERK/RSK Cascade in Insular Cortex During Novel Taste Learning , 2001, The Journal of Neuroscience.

[38]  Alcino J. Silva,et al.  Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.

[39]  Han G Brunner,et al.  Mutations in a new member of the chromodomain gene family cause CHARGE syndrome , 2004, Nature Genetics.

[40]  Dietmar Riedel,et al.  Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes , 2009, Cell.

[41]  Annette Schenck,et al.  Epigenetic Regulation of Learning and Memory by Drosophila EHMT/G9a , 2011, PLoS biology.

[42]  I. Weiler,et al.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Alcino J. Silva,et al.  Effect of Simvastatin on Cognitive Functioning in Children with Neurofibromatosis Type 1 a Randomized Controlled Trial , 2022 .

[44]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[45]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[46]  L. Vissers,et al.  Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis , 2009, Journal of Medical Genetics.

[47]  J. Goodship,et al.  Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy , 2004, Journal of Medical Genetics.

[48]  D. Stephan,et al.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. , 2006, The New England journal of medicine.

[49]  J. Opitz,et al.  A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome , 2007, Nature Genetics.

[50]  E. Kandel,et al.  Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.

[51]  J. Lilien,et al.  Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability. , 2008, American journal of human genetics.

[52]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[53]  I. Janssen,et al.  Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation , 2004, Journal of Medical Genetics.

[54]  Pierre Gressens,et al.  Many roads lead to primary autosomal recessive microcephaly , 2010, Progress in Neurobiology.

[55]  A. Munnich,et al.  Truncating Neurotrypsin Mutation in Autosomal Recessive Nonsyndromic Mental Retardation , 2002, Science.

[56]  M. Pericak-Vance,et al.  A de novo frame-shift mutation in the tuberin gene. , 1995, Human molecular genetics.

[57]  Alex Magee,et al.  Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. , 2006, American journal of human genetics.

[58]  S. Grant,et al.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.

[59]  S. Imbeaud,et al.  SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. , 2010, Human molecular genetics.

[60]  J. Gécz,et al.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.

[61]  B. Kerr,et al.  RAS-MAPK pathway disorders: important causes of congenital heart disease, feeding difficulties, developmental delay and short stature , 2010, Archives of Disease in Childhood.

[62]  Jamel Chelly,et al.  Genetics and pathophysiology of mental retardation , 2006, European Journal of Human Genetics.

[63]  J. Fryns,et al.  A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. , 2000, American journal of human genetics.

[64]  Li Li,et al.  Germline gain-of-function mutations in SOS1 cause Noonan syndrome , 2007, Nature Genetics.

[65]  A. Hoischen,et al.  Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly , 2011, Clinical genetics.

[66]  H. Brunner,et al.  Glyc‐O‐genetics of Walker–Warburg syndrome , 2004, Clinical genetics.

[67]  A. Rzhetsky,et al.  Probing genetic overlap among complex human phenotypes , 2007, Proceedings of the National Academy of Sciences.

[68]  A. Brereton,et al.  Psychopathology in Children and Adolescents with Autism Compared to Young People with Intellectual Disability , 2006, Journal of autism and developmental disorders.

[69]  S. Warren,et al.  Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function , 2008, Neuron.

[70]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[71]  D. Higgs,et al.  Molecular-clinical spectrum of the ATR-X syndrome. , 2000, American journal of medical genetics.

[72]  M. Zilbovicius,et al.  Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin‐1 gene , 2004, American journal of medical genetics. Part A.

[73]  L. Squire,et al.  Protein synthesis and memory: a review. , 1984, Psychological bulletin.

[74]  Ton Feuth,et al.  Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. , 2003, American journal of human genetics.

[75]  A. Madan,et al.  Role of MED12 in transcription and human behavior. , 2007, Pharmacogenomics.

[76]  M. Owen,et al.  The GDP-GTP Exchange Factor Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering , 2004, The Journal of Neuroscience.

[77]  Ute Moog,et al.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation , 2010, Nature Genetics.

[78]  D. Ledbetter,et al.  Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities , 2005, Journal of Medical Genetics.

[79]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[80]  Alexander R. Griffing,et al.  Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. , 2010, American journal of human genetics.

[81]  Kristen M Harris,et al.  Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.

[82]  Ben A. Oostra,et al.  Screening and Diagnosis for the Fragile X Syndrome among the Mentally Retarded: An Epidemiological and Psychological Survey , 1997 .

[83]  P. Heutink,et al.  CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. , 2003, Genomics.

[84]  J. Gécz,et al.  Mutation frequencies of X‐linked mental retardation genes in families from the EuroMRX consortium , 2007, Human mutation.

[85]  S. Laroche,et al.  Genes, plasticity and mental retardation , 2008, Behavioural Brain Research.

[86]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[87]  Peter Marynen,et al.  Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. , 2008, American journal of human genetics.

[88]  H. Ropers,et al.  Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation , 2000, Nature Genetics.

[89]  P. Caroni,et al.  Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase , 1998, Nature.

[90]  Y. Shinkai,et al.  Characterization of Drosophila G9a in vivo and identification of genetic interactants , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[91]  Alan R. Mardinly,et al.  The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc , 2010, Cell.

[92]  J. Gécz,et al.  Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.

[93]  William B Dobyns,et al.  Infantile cerebral and cerebellar atrophy is associated with a mutation in the MED17 subunit of the transcription preinitiation mediator complex. , 2010, American journal of human genetics.

[94]  R. Nussbaum,et al.  Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. , 1993, Human molecular genetics.

[95]  Jennifer K Inlow,et al.  Molecular and comparative genetics of mental retardation. , 2004, Genetics.

[96]  R. Hennekam,et al.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome , 2006, Nature Genetics.

[97]  M. Bear,et al.  Fragile X: Translation in Action , 2008, Neuropsychopharmacology.

[98]  C. Alberini,et al.  Transcription factors in long-term memory and synaptic plasticity. , 2009, Physiological reviews.

[99]  C. Hoogenraad,et al.  Dynamic Microtubules Regulate Dendritic Spine Morphology and Synaptic Plasticity , 2009, Neuron.

[100]  Stephen R. Williams,et al.  Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. , 2010, American journal of human genetics.

[101]  Ping Fang,et al.  De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome , 1997, Nature Genetics.

[102]  C. Shaw-Smith,et al.  Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects , 2009, Genetics in Medicine.

[103]  Michael J Ackerman,et al.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy , 2007, Nature Genetics.

[104]  Joseph E LeDoux,et al.  Structural plasticity and memory , 2004, Nature Reviews Neuroscience.

[105]  J. Macdonald,et al.  Abnormal Spine Morphology and Enhanced LTP in LIMK-1 Knockout Mice , 2002, Neuron.

[106]  Lin Jun,et al.  A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation , 1999, Nature Genetics.

[107]  N. Rahman,et al.  NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. , 2003, American journal of human genetics.

[108]  D. Bartsch,et al.  The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Tao Wang,et al.  Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans , 2007, Proceedings of the National Academy of Sciences.

[110]  J. Gécz,et al.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.

[111]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[112]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[113]  J. Sweatt,et al.  Cortical DNA methylation maintains remote memory , 2010, Nature Neuroscience.

[114]  E. van Binsbergen,et al.  Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. , 2009, European journal of medical genetics.

[115]  T. Kleefstra,et al.  X‐linked mental retardation: further lumping, splitting and emerging phenotypes , 2005, Clinical genetics.

[116]  Huilin Li,et al.  The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure , 2009, Cell.

[117]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[118]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[119]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[120]  Marie-Pierre Dubé,et al.  De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia , 2010, Proceedings of the National Academy of Sciences.

[121]  Guoping Fan,et al.  Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons , 2010, Nature Neuroscience.

[122]  R. Huganir,et al.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Michael A. Patton,et al.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.

[124]  R. Pfundt,et al.  A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism , 2006, Nature Genetics.

[125]  R. Stevenson,et al.  Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: A putative Rho Rac guanine nucleotide exchange factor , 1994, Cell.

[126]  J. Mowrey,et al.  Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. , 2009, American journal of human genetics.

[127]  J. Sweatt,et al.  Epigenetic Regulation of bdnf Gene Transcription in the Consolidation of Fear Memory , 2008, The Journal of Neuroscience.

[128]  E. Fombonne,et al.  Mutations in the calcium-related gene IL1RAPL1 are associated with autism. , 2008, Human molecular genetics.

[129]  Alcino J. Silva,et al.  Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 , 2002, Nature.

[130]  Albert David,et al.  X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. , 2004, American journal of human genetics.

[131]  M. Kennedy,et al.  SynGAP Regulates Steady-State and Activity-Dependent Phosphorylation of Cofilin , 2008, The Journal of Neuroscience.

[132]  M. Stratton,et al.  The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene , 2007, Journal of Medical Genetics.

[133]  R. Yuste,et al.  Morphological changes in dendritic spines associated with long-term synaptic plasticity. , 2001, Annual review of neuroscience.

[134]  J. Matson,et al.  Intellectual disability and its relationship to autism spectrum disorders. , 2009, Research in developmental disabilities.

[135]  D. Higgs,et al.  Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome) , 1995, Cell.

[136]  X. Estivill,et al.  Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment. , 2003, Cerebral cortex.

[137]  A. Vianna-Morgante,et al.  UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. , 2006, American journal of human genetics.

[138]  G. Thomas,et al.  Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype , 2007, Nature Genetics.

[139]  E. Fombonne,et al.  De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy , 2009, Annals of neurology.

[140]  Vikram Patel,et al.  No health without mental health , 2007, The Lancet.

[141]  J. Sweatt,et al.  Cognitive neuroepigenetics: A role for epigenetic mechanisms in learning and memory , 2011, Neurobiology of Learning and Memory.

[142]  T. Kirchhausen,et al.  Protein complexes containing CYFIP/Sra/PIR121 coordinate Arf1 and Rac1 signalling during clathrin–AP-1-coated carrier biogenesis at the TGN , 2010, Nature Cell Biology.

[143]  L. Villard,et al.  Polymorphisms in the C-terminal domain of MECP2 in mentally handicapped boys: implications for genetic counselling , 2002, European Journal of Human Genetics.

[144]  H. van Bokhoven,et al.  Genetic and epigenetic defects in mental retardation. , 2009, The international journal of biochemistry & cell biology.

[145]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[146]  J. Sebat,et al.  Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.

[147]  Christian Gilissen,et al.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.

[148]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[149]  Rabi Tawil,et al.  Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. , 2011, Trends in molecular medicine.

[150]  N. N. Kasri,et al.  Rho-linked genes and neurological disorders , 2008, Pflügers Archiv - European Journal of Physiology.

[151]  S. Warren,et al.  Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: A case report and review of the literature , 2008, American journal of medical genetics. Part A.

[152]  H. Bokhoven,et al.  Disruption of the epigenetic code: An emerging mechanism in mental retardation , 2010, Neurobiology of Disease.

[153]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[154]  Colin A. Johnson,et al.  Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome , 2005, Nature Genetics.

[155]  C. Woods,et al.  WDR62 is associated with the spindle pole and is mutated in human microcephaly , 2010, Nature Genetics.

[156]  C. Aoki,et al.  SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway , 2009, Nature Neuroscience.

[157]  Y. Fukushima,et al.  Haploinsufficiency of NSD1 causes Sotos syndrome , 2002, Nature Genetics.

[158]  M. Owen,et al.  TCF4, schizophrenia, and Pitt-Hopkins Syndrome. , 2010, Schizophrenia bulletin.

[159]  D. Purpura,et al.  Dendritic Spine "Dysgenesis" and Mental Retardation , 1974, Science.

[160]  C. Garner,et al.  Mechanisms of vertebrate synaptogenesis. , 2005, Annual review of neuroscience.

[161]  A. Bergman,et al.  REST and CoREST Modulate Neuronal Subtype Specification, Maturation and Maintenance , 2009, PloS one.

[162]  J. Sweatt,et al.  ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. , 2006, Learning & memory.

[163]  M. Sheng,et al.  Some assembly required: the development of neuronal synapses , 2003, Nature Reviews Molecular Cell Biology.

[164]  L. Van Aelst,et al.  Rho GTPases, dendritic structure, and mental retardation. , 2005, Journal of neurobiology.

[165]  M. Passafaro,et al.  Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation , 2009, Human molecular genetics.

[166]  N. Tommerup,et al.  Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation , 2007, Human Genetics.

[167]  P. Huttenlocher,et al.  Dendritic development in neocortex of children with mental defect and infantile spasms , 1974, Neurology.

[168]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[169]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[170]  Juliane Hoyer,et al.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). , 2007, American journal of human genetics.

[171]  Yukichi Tanaka,et al.  Germline mutations in HRAS proto-oncogene cause Costello syndrome , 2005, Nature Genetics.

[172]  P. Greengard,et al.  Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex , 2009, Neuron.

[173]  C. Schwartz,et al.  Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate , 2005, Journal of Medical Genetics.

[174]  D. Patel,et al.  Developmental disabilities across the lifespan. , 2010, Disease-a-month : DM.

[175]  Rodney C. Samaco,et al.  GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes , 2010, Nature.

[176]  G. Neri,et al.  Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys , 2010, American journal of medical genetics. Part A.

[177]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[178]  D. Ledbetter,et al.  Cryptic telomere imbalance: A 15‐year update , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[179]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[180]  Stefan Mundlos,et al.  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations , 2006, Journal of Medical Genetics.

[181]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[182]  H. Ropers,et al.  Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. , 2003, American journal of human genetics.

[183]  S. Haggarty,et al.  HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.

[184]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[185]  Andrew Menzies,et al.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.

[186]  P. Chiurazzi,et al.  XLMR genes: update 2007 , 2008, European Journal of Human Genetics.

[187]  D. Molfese,et al.  Histone Methylation Regulates Memory Formation , 2010, The Journal of Neuroscience.

[188]  C. Schwartz,et al.  Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. , 2008, Molecular cell.

[189]  Lorraine Potocki,et al.  Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. , 2007, American journal of human genetics.

[190]  A. Rao,et al.  The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation , 2007, Nature.

[191]  P. Marynen,et al.  X‐linked mental retardation: vanishing boundaries between non‐specific (MRX) and syndromic (MRXS) forms , 2002, Clinical genetics.

[192]  H. Ropers,et al.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes , 2010, Nature Genetics.

[193]  F. Benfenati,et al.  Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. , 2009, Human molecular genetics.

[194]  G. Hu,et al.  The scaffolding protein CASK mediates the interaction between rabphilin3a and β‐neurexins , 2001, FEBS letters.

[195]  R. Huganir,et al.  Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. , 2011, American journal of human genetics.

[196]  T. Südhof,et al.  Deletion of CASK in mice is lethal and impairs synaptic function , 2007, Proceedings of the National Academy of Sciences.

[197]  Christian R Marshall,et al.  Contribution of SHANK3 mutations to autism spectrum disorder. , 2007, American journal of human genetics.

[198]  Thomas W. Glover,et al.  A de novo Alu insertion results in neurofibromatosis type 1 , 1991, Nature.

[199]  M. Lalande,et al.  UBE3A/E6-AP mutations cause Angelman syndrome , 1996, Nature Genetics.

[200]  J. Gécz,et al.  Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. , 2004, American journal of human genetics.

[201]  R. Malinow,et al.  The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. , 2009, Genes & development.

[202]  L. Shaffer,et al.  The clinical utility of enhanced subtelomeric coverage in array CGH , 2007, American journal of medical genetics. Part A.

[203]  D. Blackwood,et al.  European combined analysis of the CTG18.1 and the ERDA1 CAG/CTG repeats in bipolar disorder , 2002, European Journal of Human Genetics.

[204]  E. Zackai,et al.  Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome , 1996, Nature.

[205]  M. Shaw,et al.  Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability , 2010, Nature Genetics.

[206]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.

[207]  Andrea Menegon,et al.  Mutations in GDI1 are responsible for X-linked non-specific mental retardation , 1998, Nature Genetics.

[208]  M. Rieder,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.

[209]  Sander B Nabuurs,et al.  ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. , 2006, American journal of human genetics.